Abstract:An error appeared in the corrected proof publication of this article (Siedner and Sax. "Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019." Clin Infect Dis ; https://doi.org/10.1093/cid/ciae154). An incorrect citation was used for a study discussed in the manuscript, and the manuscript did not include recent information regarding validity concerns about that trial. In the final paragraph, the sentence "Furthermore, another randomized, placebo-controlled trial of metformin, albeit with a different dosing strategy, showed no benefit [12]" should be updated to:

Correction: Silva, P.J. Computational Development of Inhibitors of Plasmid-Borne Bacterial Dihydrofolate Reductase. Antibiotics 2022, 11, 779

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Erratum for Wang et al., "Promiscuous Enzymes Cause Biosynthesis of Diverse Siderophores in Shewanella oneidensis".

Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules 2022, 27, 8282

Correction: Synthesis, docking and biological evaluation of purine-5-N-isosteres as anti-inflammatory agents

Correction: Furugaito et al. Antimicrobial Susceptibility to 27 Drugs and the Molecular Mechanisms of Macrolide, Tetracycline, and Quinolone Resistance in Gemella sp. Antibiotics 2023, 12, 1538

Correction: Photodynamic antimicrobial chemotherapy with cationic phthalocyanines against Escherichia coli planktonic and biofilm cultures

Correction: Combating Drug-Resistant Bacteria with Sulfonium Cationic Poly(methionine).

Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782

Correction: Effective in silico prediction of new oxazolidinone antibiotics: force field simulations of the antibiotic–ribosome complex supervised by experiment and electronic structure methods

Correction to “An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections”

Correction: Correia et al. Beyond Penicillin: The Potential of Filamentous Fungi for Drug Discovery in the Age of Antibiotic Resistance. 2023, 12, 1250

Corrigendum to: Recent Progress on Synthesis of Functionalized 1,5- disubstituted Triazoles

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"

Correction: The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions

Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068

Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Correction: Biogenic synthesis of silver nanoparticles using Rubus fruticosus extract and their antibacterial efficacy against Erwinia caratovora and Ralstonia solanacearum phytopathogens

Correction: Intelligent antibacterial surface based on ionic liquid molecular brushes for bacterial killing and release